Evidence-based assessment of proton-pump inhibitors in Helicobacter pylori eradication: A systematic review

被引：4

作者：

Vinayak Nagaraja ^{[1
]}

Guy D Eslick ^{[1
]}

机构：

[1] The Whiteley-Martin Research Centre, Discipline of Surgery, The University of Sydney, Nepean Hospital, Penrith, NSW 2751, Australia

来源：

World Journal of Gastroenterology | 2014年 / 40期

关键词：

Helicobacter pylori; Peptic ulcer disease; Systematic review; Proton-pump inhibitors;

D O I：

暂无

中图分类号：

R573 [胃疾病];

学科分类号：

1002 ; 100201 ;

摘要：

Peptic ulcer disease continues to be issue especially due to its high prevalence in the developing world.Helicobacter pylori(H.pylori)infection associated duodenal ulcers should undergo eradication therapy.There are many regimens offered for H.pylori eradication which include triple,quadruple,or sequential therapy regimens.The central aim of this systematic review is to evaluate the evidence for H.pylori therapy from a meta-analytical outlook.The consequence of the dose,type of proton-pump inhibitor,and the length of the treatment will be debated.The most important risk factor for eradication failure is resistance to clarithromycin and metronidazole.

引用

页码：14527 / 14536

页数：10

共 50 条

[31] Inflammatory microRNAs in gastric mucosa are modulated by Helicobacter pylori infection and proton-pump inhibitors but not by aspirin or NSAIDs
Vasapolli, Riccardo
Venerito, Marino
Schirrmeister, Wiebke
Thon, Cosima
Weigt, Jochen
Wex, Thomas
Malfertheiner, Peter
Link, Alexander
PLOS ONE, 2021, 16 (04):
[32] Efficacy of Proton-Pump Inhibitors in Children With Gastroesophageal Reflux Disease: A Systematic Review
van der Pol, Rachel J.
Smits, Marije J.
van Wijk, Michiel P.
Omari, Taher I.
Tabbers, Merit M.
Benninga, Marc A.
PEDIATRICS, 2011, 127 (05) : 925 - 935
[33] Randomized controlled trials of proton-pump inhibitors in nighttime GERD: a systematic review
Kothawala, Prajesh
Lange, Stephen
McGuigan, James
Aguilar, Daniel
Morgenstern, Diana
Yan, Ning
Dean, Bonnie
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2008, 103 : S374 - S374
[34] Addition of clidinium-C to the 14-day proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
Seyyedmajidi, Mohammadreza
Homapoor, Saba
Zanganeh, Elahe
Dadjou, Mohammad
Nejad, Shahab Eskandari
Galayeri, Mohammad Hadi Tajik
Vafaeimanesh, Jamshid
CASPIAN JOURNAL OF INTERNAL MEDICINE, 2016, 7 (02) : 78 - 81
[35] Meta-analysis:: duration of first-line proton-pump inhibitor-based triple therapy for Helicobacter pylori eradication
Fuccio, Lorenzo
Minardi, Maria Eugenia
Zagari, Rocco Maurizio
Grilli, Diego
Magrini, Nicola
Bazzoli, Franco
ANNALS OF INTERNAL MEDICINE, 2007, 147 (08) : 553 - 562
[36] Effectiveness and Safety of Vonoprazan versus Proton Pump Inhibitors for Second-Line Helicobacter pylori Eradication Therapy: Systematic Review and Meta-Analysis
Shinozaki, Satoshi
Kobayashi, Yasutoshi
Osawa, Hiroyuki
Sakamoto, Hirotsugu
Hayashi, Yoshikazu
Lefor, Alan Kawarai
Yamamoto, Hironori
DIGESTION, 2021, 102 (03) : 319 - 325
[37] Evidence for interaction between clopidogrel and proton-pump inhibitors
Last, E. J.
Sheehan, Amy Heck
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2010, 67 (08) : 605 - 606
[38] Intravenous Proton Pump Inhibitors An Evidence-Based Review of Their Use in Gastrointestinal Disorders
Bardou, Marc
Martin, Janet
Barkun, Alan
DRUGS, 2009, 69 (04) : 435 - 448
[39] Systematic review with meta-analysis: Vonoprazan, a potent acid blocker, is superior to proton-pump inhibitors for eradication of clarithromycin-resistant strains of Helicobacter pylori (vol 23, e12495, 2018)
Li, M.
Oshima, T.
Horikawa, T.
HELICOBACTER, 2021, 26 (04)
[40] Gastric consequences of proton pump inhibitor therapy and Helicobacter pylori eradication
Sachs, G
Athmann, C
Weeks, D
Scott, D
HELICOBACTER PYLORI: BASIC MECHANISMS TO CLINICAL CURE 2000, 2000, : 397 - 408

← 1 2 3 4 5 →